P.D. Soros Fellowship for New Americans

ADEL ELSOHLY is a Scientist and Group Leader at Genentech in the Protein Chemistry department within the Large Molecule Drug Discovery group. In addition, he holds a joint appointment in the Immunology Discovery group. His research focuses on the application of novel and emerging modalities to address critical unmet medical needs across a broad range of therapeutic areas.

Adel completed his postdoctoral training at UC Berkeley in 2017. In 2014, he was awarded a highly competitive Department of Defense Breast Cancer Research Program postdoctoral fellowship to use novel biomolecular materials to study signaling networks important in breast cancer progression.

He completed a PhD in chemistry at Columbia University as a National Science Foundation pre-doctoral fellow in 2012. Adel was also awarded a 2011 Roche Excellence in Chemistry prize for his graduate research prior to securing a postdoctoral research appointment at UC Berkeley.

Adel was born in Oxford, MS, the child of parents who emigrated from Egypt, are now naturalized citizens and live in Oxford, MS.

Adel completed his BS in pharmaceutical sciences, mathematics, and chemistry with election to Phi Beta Kappa and his MS in chemistry at the University of Mississippi. He held the Barry M. Goldwater scholarship.

Based on his collective research, Adel has first-author publications in a diverse array of physics, chemistry, and chemical biology journals. Throughout his academic and professional career, Adel has remained an active member of the Muslim-American community.